Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
53 participants
OBSERVATIONAL
2011-03-31
2011-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of OCT Measurements
NCT01806402
Retrospective Analysis of the Clinical Characteristics of Retinal Vein Occlusion
NCT06757595
Retinal Venous Pressure (RVP) in Normals
NCT01732042
Single In-Clinic Encounter With the Notal Vision Home OCT
NCT04642183
Performance Evaluation of OCT and OCT Angiography-based Ocular Measurements (Optical Coherence Tomography)
NCT04437082
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal
Normal results from the clinical exam and free of ocular pathology.
No interventions assigned to this group
Glaucoma
Clinical exam results consistent with glaucoma; visual field defects consistent with glaucoma and/or structural damage consistent with glaucoma.
No interventions assigned to this group
Retina
Clinical exam results consistent with retina pathology.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Glaucoma patients will have clinical exam results consistent with glaucoma; they will have visual field defects consistent with glaucoma and/or structural damage consistent with glaucoma.
* Retina patients will have clinical exam results consistent with retina pathology.
Exclusion Criteria
* Glaucoma patients will be free of any ocular pathology except glaucoma.
* Retina patients will be free of any ocular pathology except any type of retina pathology.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Optovue
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Optovue
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mike Sinai, PhD
Role: STUDY_DIRECTOR
Optovue
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pacific Eye Specialists
Daly City, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RTVue Validation Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.